Business
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results ...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n \n \n \n MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n March 28, 2023\n \n \n /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release fourth quarter financial results for the three and twelve month period ended\n \n December 31, 2022\n \n before markets open on\n \n Friday, March 31, 2023\n \n .\n \n \n \n \n \n \n \n \n \n MediPharm's executive management team will also host a conference call and audio webcast on\n \n Friday, March 31, 2023\n \n at\n \n 8:30 a.m. eastern time\n \n to discuss the Company's financial results.\n \n \n \n Audio Conference Call Dial in Details:\n \n \n \n Toll-free number: +1 (888) 330-2454 / International number: +1 (240) 789-2714\n \n \n Conference ID: 4921762\n \n \n Participants are asked to dial in approximately 15 minutes before the start of the call.\n \n \n \n Audio Webcast:\n \n \n \n An audio webcast will be available in the Events section of the MediPharm website at\n \n https://www.medipharmlabs.com/investors\n \n .\n \n \n For those who are unable to participate on the live conference call or webcast, a replay will be available approximately one hour after completion of the call.\n \n \n \n About MediPharm Labs\n \n \n \n Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed can...